Author:
Thai M,Ting P Y,McLaughlin J,Cheng D,Müschen M,Witte O N,Colicelli J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference56 articles.
1. Wong S, Witte ON . The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 2004; 22: 247–306.
2. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM . The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 1995; 55: 34–38.
3. Iijima Y, Ito T, Oikawa T, Eguchi M, Eguchi-Ishimae M, Kamada N et al. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 2000; 95: 2126–2131.
4. Deininger M, Buchdunger E, Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005; 105: 2640–2653.
5. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science (NY) 2001; 293: 876–880.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献